{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:45:38Z","timestamp":1785192338278,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.amjopharm.2012.02.003","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T14:59:54Z","timestamp":1330959594000},"page":"123-128","source":"Crossref","is-referenced-by-count":76,"title":["Polypharmacy With Common Diseases in Hospitalized Elderly Patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Fumihiro","family":"Mizokami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Noro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2012.02.003_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0895-4356(97)00306-5","article-title":"Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases","volume":"51","author":"van den Akker","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0895-4356(00)00363-2","article-title":"Causes and consequences of comorbidity: a review","volume":"54","author":"Gijsen","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2307\/3350223","article-title":"Comorbidity and its impact on disability","volume":"67","author":"Verbrugge","year":"1989","journal-title":"Milbank Q"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib4","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1001\/archinte.162.20.2269","article-title":"Prevalence, expenditures, and complications of multiple chronic conditions in the elderly","volume":"162","author":"Wolff","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03324775","article-title":"From bedside to bench: summary from the American Geriatrics Society\/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults","volume":"20","author":"Boyd","year":"2008","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib6","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1056\/NEJMsb042458","article-title":"Potential pitfalls of disease-specific guidelines for patients with multiple conditions","volume":"351","author":"Tinetti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib8","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/archinte.164.18.1957","article-title":"Polypharmacy: a new paradigm for quality drug therapy in the elderly?","volume":"164","author":"Gurwitz","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar","year":"2007","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1345\/aph.1M657","article-title":"Inappropriate prescribing predicts adverse drug events in older adults","volume":"44","author":"Lund","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: how well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/fampra\/17.3.261","article-title":"The development of polypharmacy: a longitudinal study","volume":"17","author":"Veehof","year":"2000","journal-title":"Fam Pract"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/bmj.333.7559.143","article-title":"Communicating information about drug safety","volume":"333","author":"Ferner","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11096-007-9166-3","article-title":"Polypharmacy in elderly hospitalised patients in Slovakia","volume":"30","author":"Wawruch","year":"2008","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/tcrm.2007.3.1.197","article-title":"Polypharmacy in elderly patients at discharge from the acute care hospital","volume":"3","author":"Corsonello","year":"2007","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00508-008-1089-z","article-title":"Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria","volume":"120","author":"Schuler","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib18","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4088\/JCP.08m04912gre","article-title":"Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients","volume":"71","author":"Procyshyn","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/tcrm.1.1.55.53603","article-title":"Depression and drug utilization in an elderly population","volume":"1","author":"Antonelli Incalzi","year":"2005","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.amjopharm.2012.02.003_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00228-010-0977-0","article-title":"Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards: the REPOSI study","volume":"67","author":"Nobili","year":"2011","journal-title":"Eur J Clin Pharmacol"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594612000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594612000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T09:58:48Z","timestamp":1543139928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594612000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1543594612000396"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2012.02.003","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}